Familial cancer aggregation and the risk of lung cancer
Keywords:
Lung cancer, Familial aggregation, Smoking, Case-control study, InteractionAbstract
CONTEXT: Around 90% of lung cancer worldwide is attributable to cigarette smoking, although less than 20% of cigarette smokers develop lung cancer. Other factors such as diet, chronic lung diseases, occupation and possibly environmental agents also contribute to this cancer. Genetic factors seem to play a role in lung cancer, but the precise characteristics influencing lung cancer susceptibility are not known, since genetic factors are easily obscured by the strong environmental determinants of lung cancer, particularly smoking. OBJECTIVE: To estimate the effect that cancer occurrence among first-degree relatives has on the risk of lung cancer. DESIGN: Hospital-based case-control study. SETTING: The metropolitan region of São Paulo, Brazil. PARTICIPANTS: 334 incident lung cancer cases and 578 controls matched by hospitals. MAIN MEASUREMENTS: By means of a structured questionnaire, cases and controls were interviewed about cancer occurrence in first-degree relatives, tobacco smoking, exposure to passive smoking, occupation, migration and socioeconomic status. Non-conditional logistic regression was used to calculate the risk of familial cancer aggregation, the effect of cancer in first-degree relatives and smoking in conjunction, and for controlling confounders. RESULTS: The adjusted odds ratio (OR) revealed a slight, but not statistically significant, excess risk of lung cancer for subjects with a history of lung cancer in relatives (OR 1.21; 95% confidence interval [CI] 0.50 – 2.92). The same was found among those with a history of other tobacco-related cancers in relatives (OR 1.36; 95% CI 0.87 – 2.14). A step gradient effect was observed regarding lung cancer risk, in accordance with increases in the number of pack-years of cigarette consumption. An interaction between familial cancer aggregation and tobacco smoking was detected. CONCLUSIONS: A mildly elevated risk of lung cancer among persons with a positive history of lung and other tobacco-related cancers was observed. The finding of an interaction between the variables of familial cancer aggregation and smoking suggests that familial cancer aggregation could be considered as a marker of susceptibility, increasing the risk of lung cancer among smokers. These results improve our knowledge of lung carcinogenesis and can guide future cancer genetic studies.
Downloads
References
Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking: global estimates for 1985. Int J Cancer 1994;59:494-504.
Wood ME, Kelly K, Mullineaux LG, Bunn PA Jr. The inherited nature of lung cancer: a pilot study. Lung Cancer 2000;30:135- 44.
World Health Organization. The tobacco epidemic: a global public health emergency. Tobacco Alert, April 1996. Available on website: [www.who.int/archives/tobalert/apr96/ fulltext.html].
Blot WJ, Fraumeni JF Jr. Cancers of lung and pleura. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996.p.637-65.
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first- degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-7.
Foulkes WD, Brunet JS, Kowalski LP, Narod AS, Franco EL. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer 1995;63:769-73.
Olsen JH, Boice JD Jr, Seersholm N, Bautz A, Fraumeni JF Jr. Cancer in the parents of children with cancer. N Engl J Med 1995;333:1594-9.
Anderson KE, Woo C, Olson JH, et al. Association of family history of cervical, ovarian, and uterine cancer with histological categories of lung cancer: the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev 1997;6:401-5.
Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol 1998;15:225-36.
Zhu K, Levine RS, Gu Y, et al. Non-Hodgkin’s lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 1998;9:77-82.
Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289-312.
Oii WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;76:217-22.
Shaw GL, Falk R, Pickle LW, Mason TJ, Buffler PA. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 1991;44:429-37.
Sellers TA, Elston RC, Atwood LD, Rothschild H. Lung cancer histologic type and family history of cancer. Cancer 1992;79:86-91.
Ambrosone CB, Rao U, Michalek AM, Cummings KM, Mettlin CJ. Lung cancer histologic types and family history of cancer. Analysis of histologic subtypes of 872 patients with primary lung cancer. Cancer 1993;72:1192-8.
Wu AH, Fontham ET, Reynolds P, et al. Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1996;143:535-42.
Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 1996;144:554-62.
Brownson RC, Alavanja MC, Caporaso N, Berger E, Chang JC. Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers. Int J Epidemiol 1997;26:256-63.
Kreuzer M, Kreienbrock L, Gerken M, et al. Risk factors for lung cancer in young adults. Am J Epidemiol 1998;147:1028- 37
Schwartz AG, Rothrock M, Yang P, Swanson GM. Increased cancer risk among relatives of nonsmoking lung cancer cases. Genet Epidemiol 1999;17:1-15.
Gupta D, Aggarwal AN, Vikrant S, Jindal SK. Familial aggregation of cancer in patients with bronchogenic carcinoma. Indian J Cancer 2000;37:43-49.
Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jockel KH. Aggregation of lung cancer in families: results from a population- based case-control study in Germany. Am J Epidemiol 2000;152:497-505.
Li H, Yang P, Schwartz AG. Analysis of age of onset data from case-control family studies. Biometrics 1998;54:1030-9.
Tomizawa Y, Adachi J, Kohno T, Yamaguchi N, Saito R, Yokota J. Identification and characterization of families with aggregation of lung cancer. Jpn J Clin Oncol 1998;28:192-5.
Gauderman WJ, Morrison JL. Evidence for age-specific genetic relative risks in lung cancer. Am J Epidemiol 2000;151:41-9.
Ministério da Saúde [Ministry of Health]. Fundação Nacional de Saúde [National Health Foundation]. Sistema de Informações sobre Mortalidade [Mortality information system]. Dados de Declaração de Óbito 1979-1996 [Data from Death Certificate 1979-1996]. Brasília, DF: Centro de Documentação do Ministério da Saúde [Ministry of Health Documentation Center]; 1997.
Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. Lyon: IARC Press; 1993. (IARC Scientific Publications N. 121).
Fonseca LAM. A evolução das doenças neoplásicas [Evolution of neoplastic diseases]. In: Monteiro CA, editor. Velhos e novos males da saúde no Brasil: a evolução do país e de suas doenças [New and old health problems in Brazil: the evolution of the country and its diseases]. São Paulo: Hucitec; 1995.p.268-78.
Hamada GS, Sugimura H, Suzuki I, et al. The heme-binding region polymorphism of cytochrome P450lA1 (Cyp1A1), rather than the Rsal polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarkers Prev 1995;4:63-7.
Wünsch-Filho V, Moncau JEC, Mirabelli D, Boffetta P. Occupational risk factors of lung cancer in São Paulo, Brazil. Scand J Work Environ Health 1998;24:118-24.
World Health Organization. International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injury and Causes of Death. Ninth Revision, 1975. Geneva: World Health Organization; 1975.
Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1: The analysis of case-control studies. Lyon: IARC Press; 1980. (IARC Scientific Publications N. 32).
Suzuki L, Hamada GS, Zamboni MM, Cordeiro PB, Watanabe S, Tsugane S. Risk factors for lung cancer in Rio de Janeiro, Brazil: a case-control study. Lung Cancer 1994;11:179-90.
Susser M. Separating heredity and environment. Am J Prev Med 1985;1:5-23.
Yang P, Schwartz AG, McAllister AE, Aston CE, Swanson GM. Genetic analysis of families with nonsmoking lung cancer probands. Genet Epidemiol 1997;14:181-97.
Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol 1999;17:253-73.
Vineis P, Malats N, Boffetta P. Why study metabolic susceptibility to cancer? In: Vineis P, Malats N, Lang M, d’Errico A, Caporaso N, Cuzick J, Boffetta P. Metabolic polymorphisms and susceptibility to cancer. Lyon: IARC Press; 1999.p.1-3. (IARC Scientific Publications N. 148).
Skeel RT, Schiefeling DJ, Horton J, Talefski TJ. Practical guide to cancer genetics, origin and prevention. Disease-a-month 1997;43:692-715.
Love RD, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chrn Dis 1985;38:289-93.
Bergen AW, Caporaso N. Cigarette smoking. J Natl Cancer Inst 1999;91:1365-75.
Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirnoven A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility – a review. Gene 1995;159:113-21.
Nazar-Stewart V, Motulsky AG, Eaton DL, et al. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993;53(Suppl 10):2313-8.
Nakagima T, Elovaara E, Anttila S, et al. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 1995;16:707-11.
Bartsch H, Rojas M, Nair U, Nair J, Alexandrov K. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke-oven workers. Cancer Detect Prev 1999;23:445-53.
Butkiewicz D, Grzybowska E, Phillips DH, Hemminki K, Chorazy M. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ Mol Mutagen 2000;35:99-105.
Heckbert SR, Weiss NS, Hornung SK, Eaton DL, Motulski AG. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J Natl Cancer Inst 1992;84:414-22.
Jourenkova-Mironova N, Wikman H, Bouchardy C, et al. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking- related lung cancer. Pharmacogenetics 1998;8:495-502.
Wünsch-Filho V, Gattás GJF. Biomarcadores moleculares em câncer: implicações para a pesquisa epidemiológica e a saúde pública. Cad Saúde Pública 2001;17:467-80.
